Carrie Eckert became the Synthetic Biology group leader at Oak Ridge National Laboratory in July 2021 following previous appointments at the National Renewable Energy Laboratory and the University of Colorado, Boulder. Her research is focused on developing tools to enable and accelerate the genetic manipulation and metabolic engineering of a number of model an non-model microbial systems. Specifically, she is most interested in the development of high throughput, CRISPR-based methods for genotype-phenotype discovery for applications in metabolic engineering towards the production of bio-derived chemicals.